Drawing for XIDARVO

USPTO serial 79218651

XIDARVO

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
KOVALSKY, LAURA G
Law office
TTAB

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 604: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with XIDARVO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Bassam N. Ibrahim

BASSAM N IBRAHIM BUCHANAN INGERSOLL & ROONEY PC1737 KING STREET SUITE 500ALEXANDRIA, VA 22314UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment and prevention of cardiovascular disease, stroke, dyslipidemia, thrombosis, hyperphosphatemia, diabetes, cancer, oncological disease, leukemia, metastasis, bacterial infection, viral infection, pain, central nervous system diseases, neurological diseases, mood disorders, spinal cord injury, musculoskeletal disorders, osteoporosis, age-related macular degeneration, kidney diseaseABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 24, 2020FINTFINAL DECISION TRANSACTION PROCESSED BY IB—
Jan 9, 2020FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jan 9, 2020FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 26, 2019NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jan 9, 2019MAB4ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION—
Jan 9, 2019ABN4ABANDONMENT - AFTER INTER PARTES DECISION—
Jan 9, 2019OP.TOPPOSITION TERMINATED NO. 999999—
Jan 9, 2019OP.SOPPOSITION SUSTAINED NO. 999999—
Oct 19, 2018RFNPREFUSAL PROCESSED BY IB—
Oct 1, 2018OP.IOPPOSITION INSTITUTED NO. 999999—
Sep 27, 2018OPNSOPPOSITION NOTICE (IB REFUSAL) SENT TO IB—
Sep 27, 2018OPNCOPPOSITION NOTICE (IB REFUSAL) CREATED—
Jun 28, 2018ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Jun 2, 2018GPNXNOTIFICATION PROCESSED BY IB—
May 29, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 29, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 16, 2018OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 16, 2018OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
May 9, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 24, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 24, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 24, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 24, 2018ALIEASSIGNED TO LIE—
Apr 16, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 16, 2018TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 24, 2017RFNTREFUSAL PROCESSED BY IB—
Nov 3, 2017RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Nov 3, 2017RFRRREFUSAL PROCESSED BY MPU—
Oct 27, 2017RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Oct 26, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 25, 2017DOCKASSIGNED TO EXAMINER—
Oct 24, 2017MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 20, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 19, 2017REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance